Perceptive Advisors LLC Centessa Pharmaceuticals PLC Transaction History
Perceptive Advisors LLC
- $2.28 Billion
- Q2 2025
A detailed history of Perceptive Advisors LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Perceptive Advisors LLC holds 1,146,935 shares of CNTA stock, worth $19.6 Million. This represents 0.66% of its overall portfolio holdings.
Number of Shares
1,146,935
Previous 3,040,395
62.28%
Holding current value
$19.6 Million
Previous $43.7 Million
65.53%
% of portfolio
0.66%
Previous 1.83%
Shares
6 transactions
Others Institutions Holding CNTA
# of Institutions
127Shares Held
122MCall Options Held
638KPut Options Held
146K-
Medicxi Ventures Management (Jersey) LTD20MShares$342 Million74.33% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$170 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$166 Million4.43% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.4MShares$144 Million0.2% of portfolio
-
Janus Henderson Group PLC London, X06.53MShares$112 Million0.04% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.61B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...